Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2017030632913N1Phase 2Completed
Phase 2, open-label trial of urea in radiodermatitis and head and neck cancer (HNC) (2 arms), sponsored by Firoozgar Clinical Research Development Center. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2017030632913N1.